The study will use the same vitamins that I alluded to from England, Vitamin C and Vitamin E. These are not vitamins anymore. I should refer to them formally because at the doses they’re given they’re way beyond replacement therapy. They’re maybe 10 to 100 times higher. They’ll collect the data and biological materials. The primary outcomes may be severe growth restriction, and infant death after 20 weeks gestation. The power analysis is designed to come up with a 30% reduction in primary outcome.